During the past decade, Dorset Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dorset Cancer Centre" #1 sponsor was "Medical Research Council" with 4 trials, followed by "University College, London" with 2 trials sponsored, "University of Leeds" with 2 trials sponsored, "University of Southampton" with 2 trials sponsored and "Wales Cancer Trials Unit" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dorset Cancer Centre" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "University Hospital Southampton NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Dorset Cancer Centre" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Metastatic Cancer" (4 trials), "Lung Cancer" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Dorset Cancer Centre" in a lesser frequency.

Most popular intervention types in "Dorset Cancer Centre" are "Drug" (22 trials), "Biological" (11 trials), "Procedure" (11 trials), "Radiation" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (7 trials), "capecitabine" (6 trials), "quality-of-life assessment" (6 trials), "neoadjuvant therapy" (5 trials) and "carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Dorset Cancer Centre" are 17 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Dorset Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Dorset Cancer Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dorset Cancer Centre, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".